Mitochondrial biogenesis, the second arm of mitochondrial turnover controlled by AMPK, was evaluated by measuring the expression level of TFAM in cells from patients with CS using Q-PCR (Figure 4O). This evidence concerns the gene TFAM and Cowden syndrome 1.